Website & contact details
- Website
Alchemab Therapeutics Ltd
- Incorporated
- 14 August 2019 (7 years)
- Industry
- Research and experimental development on biotechnology (72110)
- Directors
- Andrew Paul MayJenna Hebert
- Accounts type
- Group
- Region
- Greater London
- Address
- East Side Office 1.02Kings CrossLondonN1C 4AX
Filing status
- Accounts due
- 30 September 2027
- Last accounts
- 31 December 2025
- Conf. stmt due
- 12 December 2026
- Last conf. stmt
- 28 November 2025
Charges
- Total
- 1
- Outstanding
- 0
- Part satisfied
- 0
- Satisfied
- 1
Officers 7 active
Officer details are public data from the Companies House register.
Director · Appointed 17 June 2026
British
Born March 1986 (40)
May, Andrew Paul, Dr
Director · Appointed 4 June 2026
British
Born April 1973 (53)
Hebert, Jenna
Director · Appointed 28 May 2026
American
Born March 1994 (32)
Gates, Malcolm Derek
Secretary · Appointed 5 March 2026
Osbourn, Jane Katharine
Director · Appointed 11 September 2024
British
Born March 1966 (60)
Director · Appointed 26 July 2023
British
Born October 1965 (61)
Director · Appointed 30 June 2021
English
Born April 1968 (58)
Officer history (8 former)
17 June 2026
4 June 2026
Appointed May, Andrew Paul, Dr as Director
4 June 2026
Resigned Hamer, John as Director
28 May 2026
Appointed Hebert, Jenna as Director
21 May 2026
5 March 2026
Appointed Gates, Malcolm Derek as Secretary
11 September 2024
Appointed Osbourn, Jane Katharine as Director
11 September 2024
Resigned Kwon, Young T., Mr. as Director
26 July 2023
26 July 2023
25 May 2022
Appointed Kwon, Young T., Mr. as Director
22 April 2022
Resigned Treco, Douglas, Dr as Director
30 June 2021
13 April 2021
13 April 2021
13 April 2021
Appointed Treco, Douglas, Dr as Director
13 April 2021
Appointed Hamer, John as Director
13 April 2021
13 April 2021
9 April 2020
14 August 2019
14 August 2019
14 August 2019
Ownership 0 active
People and entities with significant control, from the Companies House PSC register
The company has declared that it has no person with significant control.
Former controllers (2)
13 April 2021
Ceased SV7 (Imf) GP LLP — Owns 25–50% of shares (as a firm)
2 April 2020
Ceased Dementia Discovery GP LP — Owns 25–50% of shares
Filings 92
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 30 September 2026 | Group of companies' accounts | 31 December 2025 | ||
| 14 July 2026 | Statement of capital following an allotment of shares | |||
| 14 July 2026 | Statement of capital following an allotment of shares | |||
| 7 July 2026 | Memorandum and Articles of Association | |||
| 7 July 2026 | Resolutions |
Other companies in this industry
By trade and location
Explore the largest companies
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →